DHI SIGNAL · FILING RESEARCH

PG Days sales outstanding

Days sales outstanding at Procter & Gamble rose to 26.8 days in fiscal 2025, the highest in the 5 years reported, from 26.6 days in 2024.

Year-end receivables divided by total revenue, times 365. Both inputs as filed.

SOURCE: us-gaap:AccountsReceivableNetCurrent + us-gaap:Revenues · EDGAR CompanyFacts · CIK 80424 · EDGAR ↗ · FY2021–FY2025 · ANNUAL

FY202526.8 days
FY2024 26.6 days
HIGH26.8 days FY2025
LOW22.7 days FY2021

History AS FILED · DERIVATION SHOWN WHERE DERIVED

Fiscal yearReceivablesRevenueDSO
FY2025$6.2B$84.3B26.8 days
FY2024$6.1B$84.0B26.6 days
FY2023$5.5B$82.0B24.4 days
FY2022$5.1B$80.2B23.4 days
FY2021$4.7B$76.1B22.7 days

Cross-checks touching this measure FROM THE FILING REVIEW

✓ MATCHESnet sales growth

Every quoted figure reconciles to the filed lines: $87.0 billion against total revenues; 3% against total revenues.

FY2026 10-K · FULL RECONCILIATION →

✓ MATCHESoperating income decline

Every quoted figure reconciles to the filed lines: $703 million against operating income; $19.7 billion against operating income; 3% against operating income.

FY2026 10-K · FULL RECONCILIATION →

◐ PARTLYSG&A increase

2 of 3 quoted figures reconcile ($23.9 billion against selling, general and administrative; 6% against selling, general and administrative); 27.5% does not map to a filed line on this page — carried as partly supported.

FY2026 10-K · FULL RECONCILIATION →

✓ CLEANReceivables pace

Days sales outstanding moved -1.4 days — inside the ±7-day watch threshold.

FY2026 10-K · FULL RECONCILIATION →

✓ CLEANInventory vs revenue pace

Inventory moved +8.2%, revenue +3.3% (gap +4.9pp). The flag tests inventory OUTRUNNING revenue by more than 7pp.

FY2026 10-K · FULL RECONCILIATION →

More SAME DATA, OTHER VIEWS

Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.